Stay updated on Efficacy and Safety of GP2017 vs Humira Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of GP2017 vs Humira Clinical Trial page.

Latest updates to the Efficacy and Safety of GP2017 vs Humira Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedPublications section updated: added a plain-language summary of the ADACCESS trial (Immunotherapy, 2026 Jan) and removed the earlier February 2026 'Online ahead of print' citation.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedA new publication entry was added to the Publications section for the ADACCESS trial. The article 'Betteridge et al., Comparison of treatment with GP2017 (an adalimumab biosimilar) and reference adalimumab in people with plaque psoriasis: a plain language summary of the ADACCESS trial' is now listed with full citation details.SummaryDifference0.0%

- Check52 days agoChange DetectedMinor revision metadata updated from v3.4.1 to v3.4.2; no core content or user-facing features are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedUpdated the page’s revision metadata from v3.4.0 to v3.4.1, replacing the previous revision entry.SummaryDifference0.0%

Stay in the know with updates to Efficacy and Safety of GP2017 vs Humira Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of GP2017 vs Humira Clinical Trial page.